<DOC>
	<DOCNO>NCT00752401</DOCNO>
	<brief_summary>The purpose study evaluate effect Cholecalciferol ( Vitamin D3 ) substitution posttransplant outcome ( glomerular filtration rate well serum creatinine level , number acute rejection episode , number infection C-reactive protein level within first year transplantation ) vitamin D deficient kidney transplant recipient .</brief_summary>
	<brief_title>Vitamin D3 Substitution Vitamin D Deficient Kidney Transplant Recipients</brief_title>
	<detailed_description>Apart classical action calcium homeostasis , vitamin D act potent immunomodulatory agent . As , vitamin D think beneficial effect transplant setting , especially kidney transplant recipient consider fact approximately 40 % kidney transplant recipient vitamin D deficient . Therefore , objective conduct randomize , double-blind , placebo-controlled study focus impact Cholecalciferol substitution vitamin D deficient kidney transplant recipient graft function ( glomerular filtration rate well serum creatinine level ) , incidence acute rejection episode , frequency severity ( CRP level ) posttransplant infection within first year kidney transplantation . Moreover , impact Vitamin D3 renal osteodystrophy analyze mean bone mineral density . DXA measurement perform first four week kidney transplantation , 5 , 12 month posttransplant . Kidney transplant recipient find vitamin D deficiency ( define 25-hydroxyvitamin D &lt; 50 nmol/l ) include randomize receive either oral Vitamin D3 therapy placebo . Vitamin D3 administer daily dose 6800IU time period one year . All , 200 subject include VITA-D study .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Renal Osteodystrophy</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>age &gt; 18 deceased donor kidney transplant recipient kidney transplant recipient vitamin D deficiency define 25 ( OH ) D &lt; 50nmol/l retransplantation second time patient highly immunize therefore included aphaeresis program retransplantation third time significant impaired intestinal resorption : malabsorption due celiac sprue , systemic scleroderma ; maldigestion due chronic pancreatitis , pancreatic insufficiency , pancreas resection , mucoviscidosis , ZollingerEllisonsyndrome history inflammatory bowel disease : Crohn 's disease , ulcerative colitis previous gastrectomy , small bowel large bowel resection , intestinal bypass surgery severe liver disease : cirrhosis HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Vitamin D3</keyword>
	<keyword>25-hydroxyvitamin D3</keyword>
	<keyword>Immunomodulation</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Renal transplantation</keyword>
	<keyword>Graft function</keyword>
	<keyword>Acute rejection</keyword>
	<keyword>Renal osteodystrophy</keyword>
	<keyword>Posttransplant bone loss</keyword>
</DOC>